Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Glaxosmithkline Plc (GSK)

Glaxosmithkline Plc (GSK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,995,480
  • Shares Outstanding, K 2,508,520
  • Annual Sales, $ 43,783 M
  • Annual Income, $ 7,382 M
  • 60-Month Beta 0.70
  • Price/Sales 1.97
  • Price/Cash Flow 10.51
  • Price/Book 3.23
Trade GSK with:

Options Overview

Details
  • Implied Volatility 22.63%
  • Historical Volatility 25.71%
  • IV Percentile 26%
  • IV Rank 4.81%
  • IV High 161.10% on 03/16/20
  • IV Low 15.63% on 09/14/20
  • Put/Call Vol Ratio 0.64
  • Today's Volume 1,281
  • Volume Avg (30-Day) 5,696
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 61,460
  • Open Int (30-Day) 93,515

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.59
  • Number of Estimates 2
  • High Estimate 0.66
  • Low Estimate 0.52
  • Prior Year 0.97
  • Growth Rate Est. (year over year) -39.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.24 +0.38%
on 02/22/21
39.31 -12.56%
on 01/26/21
-4.55 (-11.69%)
since 01/25/21
3-Month
34.24 +0.38%
on 02/22/21
39.31 -12.56%
on 01/26/21
-2.86 (-7.68%)
since 11/25/20
52-Week
31.43 +9.35%
on 03/23/20
43.38 -20.78%
on 03/04/20
-7.11 (-17.14%)
since 02/25/20

Most Recent Stories

More News
Nutraceuticals Market Size Worth USD 407,650 Million by 2025 at 7.37% CAGR | Growing Need for Immunity Boosters to Increase the Nutraceuticals Demand, Says Market Research Future (MRFR)

Nutraceuticals Market Overview:

ABT : 121.54 (-0.69%)
BTCA : 120,000.0000 (unch)
DANOY : 14.2750 (+0.88%)
GLAPF : 12.4000 (unch)
GSK : 34.47 (-0.61%)
PRGO : 40.99 (-1.61%)
YKLTY : 26.0000 (+0.39%)
Toothpaste Market Valuation to Reach USD 21,642 Million by 2025 at 4.80% CAGR, Estimates Market Research Future (MRFR)

Toothpaste Market Overview:

CHD : 79.11 (-0.55%)
CL : 76.59 (-0.07%)
GSK : 34.47 (-0.61%)
HENKY : 22.4400 (-1.15%)
LGHHF : 644.2160 (unch)
PG : 126.75 (-0.71%)
UL : 53.93 (-0.61%)
Worldwide Cephalosporin Industry to 2026 - by Generation, Route of Administration, Application and Region

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
BMY : 62.43 (-0.26%)
GSK : 34.47 (-0.61%)
MRK : 74.68 (+0.15%)
NVS : 87.01 (-0.48%)
PFE : 33.78 (+0.09%)
TEVA : 11.10 (-1.94%)
Theravance (TBPH) Q4 Earnings Top Estimates, Revenues In Line

Theravance's (TBPH) loss narrows in the fourth quarter of 2020 while revenues meet the consensus estimate.

JNJ : 163.04 (+0.28%)
GSK : 34.47 (-0.61%)
TBPH : 17.56 (+0.40%)
VTRS : 15.06 (-1.57%)
Global Cancer Pain Management Solutions Market 2020 Industry Status and Outlook, Competitive Landscape and Growth by 2025

is extremely much required in some ways for business growth and to thrive within the market. In this report, industry trends are given intimately, which makes it possible to outline the market landscape...

ENDP : 9.55 (-3.24%)
GSK : 34.47 (-0.61%)
VRX.TO : 30.80 (-3.33%)
Biologics Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Biologics Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027732/?utm_source=GNW

BMY : 62.43 (-0.26%)
GSK : 34.47 (-0.61%)
Sports Drink Market Size to Hit $32.61 Billion by 2026 | Fortune Business Insights(TM)

According to Fortune Business Insights(TM), the global sports drink market size is expected to reach $32.61 billion by 2026. The rising emphasis on improving body's performance and endurance level by athletes...

GSK : 34.47 (-0.61%)
NSRGY : 105.5600 (-0.90%)
Vitamin and Mineral Supplements Market Size Worth USD 108.14 Billion by 2025 at 6.70% CAGR, Predicts Market Research Future (MRFR)

Key Aspects Set to Influence the Industry

ABT : 121.54 (-0.69%)
BAYRY : 15.7400 (-6.23%)
GLAPF : 12.4000 (unch)
GSK : 34.47 (-0.61%)
OTSKY : 20.5100 (-3.39%)
Smart Inhalers Market Size Worth USD 4725.69 Million by 2025 at 4.2% CAGR | Growing Incidence of Chronic Respiratory Diseases to Boost Global Industry, Says Market Research Future (MRFR)

Smart Inhalers Market Overview:

GSK : 34.47 (-0.61%)
Outlook on the Cephalosporin Global Market to 2026 - Players Include Allergan, GlaxoSmithKline and Lupin Among Others

The "Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

AGN : 193.02 (+0.02%)
GSK : 34.47 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central...

See More

Key Turning Points

3rd Resistance Point 35.14
2nd Resistance Point 34.95
1st Resistance Point 34.81
Last Price 34.47
1st Support Level 34.48
2nd Support Level 34.29
3rd Support Level 34.15

See More

52-Week High 43.38
Fibonacci 61.8% 38.82
Fibonacci 50% 37.41
Fibonacci 38.2% 36.00
Last Price 34.47
52-Week Low 31.43

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar